1. Home
  2. RH vs SYRE Comparison

RH vs SYRE Comparison

Compare RH & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RH

RH

RH

HOLD

Current Price

$218.90

Market Cap

3.2B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$30.57

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RH
SYRE
Founded
1979
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.6B
IPO Year
1998
2016

Fundamental Metrics

Financial Performance
Metric
RH
SYRE
Price
$218.90
$30.57
Analyst Decision
Hold
Strong Buy
Analyst Count
16
6
Target Price
$227.33
$56.50
AVG Volume (30 Days)
1.3M
777.4K
Earning Date
12-11-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
57.11
N/A
EPS
5.52
N/A
Revenue
$3,409,319,000.00
N/A
Revenue This Year
$12.43
N/A
Revenue Next Year
$8.89
N/A
P/E Ratio
$39.66
N/A
Revenue Growth
9.74
N/A
52 Week Low
$123.03
$10.91
52 Week High
$455.84
$35.31

Technical Indicators

Market Signals
Indicator
RH
SYRE
Relative Strength Index (RSI) 77.46 48.15
Support Level $202.22 $29.60
Resistance Level $189.68 $31.69
Average True Range (ATR) 10.43 1.49
MACD 3.98 -0.61
Stochastic Oscillator 93.97 38.96

Price Performance

Historical Comparison
RH
SYRE

About RH RH

RH is a luxury furniture and lifestyle retailer operating in the $136 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories including furniture, lighting, textiles, bath, decor, and children and is growing the presence of its hospitality business with 23 restaurant locations, including RH Guesthouse. RH innovates, curates, and integrates products, categories, services, and businesses across channels and brand extensions (RH Modern and Waterworks, for example). RH is fully integrated across channels and is positioned to broaden its addressable market over the next decade via expanding abroad, its World of RH digital platform (highlighting offerings outside of home furnishings), and offerings in architecture, media, and more.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: